Rosso
Rosso is an Italian digital health platform operating a mobile app and B2B software (EmaOS) that connects blood and plasma donors to collection centers, corporate employers, and donor associations across Italy.
- Company typePrivate
- Founded2023
- HeadquartersMilano, Italy
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Rosso does
Rosso, a brand operated under Ema Health S.r.l. (legal entity in Italy), is a digital health platform for blood and plasma donation. Founded in 2023 by Chiara Schettino and Filippo Toni and headquartered in Mercogliano with operational offices in Milano and Lucca, the company operates a consumer-facing mobile application (iOS and Android) that enables Italian donors to check eligibility via a 30-question in-app quiz, book donations at preferred collection centers in approximately 30 seconds, track personal donation history, and receive automated reminders for next eligible donation dates.
The underlying technology spans two products: the Rosso consumer app and EmaOS, a B2B platform for blood collection centers and donor associations that handles reservations, donor records, and scheduling. The platform targets three customer segments: individual blood and plasma donors (primary), corporate employers via the Corporate Life Savers program, and collection centers/donor associations via EmaOS. Distribution is mobile-app-first with app store presence and a web app, supplemented by B2B enterprise sales for the corporate program.
The business model is not explicitly disclosed. The consumer app is offered free of charge, while monetization is implied to flow from B2B channels — Corporate Life Savers enterprise engagements and EmaOS licensing to collection centers — though pricing structures, contract values, and revenue figures are not publicly available. The company is GDPR-compliant and processes sensitive health data under EU regulatory frameworks. As of mid-2026, Rosso reports 10,000+ monthly active donors, a team of 25+ people, and €3M in cumulative disclosed funding led by 360 Capital with Cassa Depositi e Prestiti and Angelini.
Rosso firmographics
Firmographics- Name
- Rosso
- Legal name
- Ema Health S.r.l.
- Website
- https://donarosso.it
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Rosso is an Italian digital health platform operating a mobile app and B2B software (EmaOS) that connects blood and plasma donors to collection centers, corporate employers, and donor associations across Italy.
- Ownership category
- akta.pro rank
Rosso industry classification
Industry- Product category
- Blood Donation Management Software
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
- akta.pro secondary industries
- Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Rosso is headquartered
LocationHeadquarters
- HQ city
- Milano
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
Rosso business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- App Services: Free mobile app for individual donors to discover eligibility, book donations, and track history. Revenue model not explicitly disclosed - likely subscription/licensing from B2B segment or data monetization within regulatory compliance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free donor app |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Rosso product offering
Product offeringCore offering
Rosso develops a mobile application (iOS/Android) and web platform that enables Italian users to discover blood and plasma donation eligibility, book donation appointments at collection centers in approximately 30 seconds, and track their personal donation history with automated reminders for recurring donations. Through its parent EmaHealth, Rosso also offers EmaOS, a unified backend platform for blood collection centers and donor associations managing reservations, donor records, and scheduling, plus a Corporate Life Savers program enabling Italian companies to run employee blood donation initiatives.
Product overview
Rosso is a digital health platform for blood and plasma donation in Italy, consisting of a consumer-facing mobile application (Rosso) and an enterprise-grade platform (EmaOS) for collection centers and donor associations. The Rosso app enables donors to check eligibility, book appointments in 30 seconds, and track their donation history. EmaOS serves as the backend infrastructure for managing reservations, donors, and schedules. The Corporate Life Savers program extends the platform to enterprise clients, enabling corporate blood donation initiatives.
Differentiator
Problem solved
Functional benefit
Brands
- EmaOS: A single platform for reservations, donors and scheduling for blood collection centers and donor associations.
Products and services
- Rosso App Free mobile and web application for Italian blood and plasma donors to check eligibility via an anonymous 30-question quiz, book appointments in 30 seconds at preferred collection centers, track donation history, and receive reminders for next eligible donation.
- EmaOS Enterprise platform for blood collection centers and donor associations providing a single system for managing reservations, donor records, and appointment scheduling across the Italian transfusion medicine supply chain.
- Corporate Life Savers
Quantifiable outcome
- One donation can save up to three lives
Companies that use Rosso
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Rosso technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Rosso partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Rosso competitors and assessment
Company assessmentBroad incumbents
- FIDAS: Second major Italian blood donor association federation, with affiliated local donor groups across the country. Directly comparable to AVIS as an institutional competitor and potential B2B partner or blocker for Rosso's EmaOS rollout.
- Haemonetics: Global blood management company providing plasma collection software and donor management technology to plasma centers. Comparable to EmaOS in serving plasmapheresis centers, the specific donor segment Rosso prioritizes.
- AVIS (Associazione Volontari Italiani del Sangue): Italy's largest blood donor association with millions of members and direct institutional relationships with the SSN. It is the dominant incumbent that Rosso must convince donors and collection centers to route through, and could itself launch a competing digital platform.
- Octapharma Plasma: One of the world's largest plasma collection operators with its own donor apps and scheduling systems. Comparable as a vertically integrated plasma collection incumbent whose digital tooling competes with Rosso's plasma-booking proposition.
- CSL Plasma: Global plasma collection network operated by CSL Behring, with proprietary donor scheduling and loyalty applications. Relevant comparable as a plasma-specific incumbent building consumer-facing donor tech at global scale.
- WellSky (Blood Bank / Blood Centers division): Large US healthcare software vendor with a dedicated blood bank and donor management suite sold to hospitals and centers. Comparable as a more mature, scaled competitor to EmaOS for transfusion medicine workflow software.
- Grifols: Global plasma-derived therapies company operating one of the largest plasma donor networks with its own donor management platforms. Comparable as a plasma-category incumbent with consumer-facing donor digital infrastructure.
Regional players
- Vitalant: One of the largest US nonprofit blood collection organizations operating donor scheduling and recruitment tools across hundreds of centers. Comparable as a donor-centric collection operator whose digital platform parallels Rosso's EmaOS + Rosso consumer layer.
Direct peers
- InVita (formerly Hemasoft / Blood Bank Computer Systems): US-based supplier of blood and plasma management software (recruitment, donor scheduling, inventory) to blood centers and hospitals. Closest international comparable to EmaOS as a B2B platform for collection centers and donor associations.
- BloodHub: US-focused blood supply chain and donor management SaaS used by blood centers. Comparable to EmaOS in serving the operational and scheduling layer of transfusion medicine.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Rosso social profiles
Digital presenceRosso compliance and trust
Trust signalCompliance2 records
Rosso financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rosso leadership team
Management profileNumber of profiles
Profiles2 records
Rosso funding detail
Funding detailFunding overview
Funding rounds3 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rosso M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rosso
What does Rosso do?
Rosso develops a mobile application (iOS/Android) and web platform that enables Italian users to discover blood and plasma donation eligibility, book donation appointments at collection centers in approximately 30 seconds, and track their personal donation history with automated reminders for recurring donations. Through its parent EmaHealth, Rosso also offers EmaOS, a unified backend platform for blood collection centers and donor associations managing reservations, donor records, and scheduling, plus a Corporate Life Savers program enabling Italian companies to run employee blood donation initiatives.
Is Rosso a public or private company?
Rosso is a private company. It is classified as venture growth investor backed and is currently operating.
When was Rosso founded?
Rosso was founded in 2023. It employs 1 to 10 people.
Where is Rosso based?
Rosso is headquartered in Milano, Italy, in the Europe region.
How does Rosso make money?
One revenue line is on record: app Services.
Who are Rosso's main competitors?
Broad incumbents on record are FIDAS, Haemonetics, AVIS (Associazione Volontari Italiani del Sangue), Octapharma Plasma, CSL Plasma, WellSky (Blood Bank / Blood Centers division) and Grifols. Vitalant is listed as a regional player. Direct peers are InVita (formerly Hemasoft / Blood Bank Computer Systems) and BloodHub.
Does Rosso have an API?
No public API is recorded for Rosso.
What industry is Rosso in?
Rosso's product category is Blood Donation Management Software. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of BPAGACAJ, Blood, Organ & Tissue Donation Organizations. Its NAICS code is 621991.